Who
Yuri Maricich
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, CAMP4 Therapeutics; Chief Medical Officer, Pear Therapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 2
- Sells
- 1
- Bought
- $32K
- Sold
- $14K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 3 Dec 2021
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $11K6,551 at $1.65 | filing |
| 3 Aug 2026filed 5 Aug 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $11K6,551 at $1.65 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —215,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —215,000 at $0.00 | filing |
| 11 Dec 2025filed 22 Dec 2025 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 11 Sep 2025filed 11 Sep 2025 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $9,9996,060 at $1.65 | filing |
| 1 Apr 2025filed 3 Apr 2025 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 15 Feb 2023filed 17 Feb 2023 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —1,333,333 at $0.00 | filing |
| 20 Jan 2023filed 24 Jan 2023 | Pear Therapeutics | SEC FORM 4 Sold | $14K12,162 at $1.13 | filing |
| 14 Jan 2023filed 18 Jan 2023 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code M | —30,800 at $0.00 | filing |
| 14 Jan 2023filed 18 Jan 2023 | Pear Therapeutics | SEC FORM 4 Code M | —30,800 at $0.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —73,528 at $0.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —93,333 at $0.00 | filing |
| 3 Dec 2021filed 7 Dec 2021 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —73,620 | filing |
| 3 Dec 2021filed 7 Dec 2021 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —44,172 | filing |
| 3 Dec 2021filed 7 Dec 2021 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —176,689 | filing |
| 3 Dec 2021filed 7 Dec 2021 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —103,068 | filing |
| 3 Dec 2021filed 7 Dec 2021 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —88,344 | filing |
| 3 Dec 2021filed 7 Dec 2021 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —103,068 | filing |
| 3 Dec 2021filed 7 Dec 2021 | Pear Therapeuticsoption or derivative | SEC FORM 4 Code A | —220,862 | filing |
News
No headline names them, or the companies they trade most, lately.